Horizon Therapeutics Public Ltd Co

SEGALL BRYANT & HAMILL, LLC

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

3,798

Value ($000)

391

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	391	0.0%	3,798	6/30/2023
2023 Q1	5/15/2023	414	0.0%	3,798	3/31/2023
2022 Q4	2/14/2023	14,855	0.2%	130,544	12/31/2022
2022 Q3	11/14/2022	11,248	0.1%	181,693	9/30/2022
2022 Q2	8/15/2022	10,975	0.1%	137,621	6/30/2022
2022 Q1	5/13/2022	17,118	0.2%	162,715	3/31/2022
2021 Q4	2/14/2022	14,214	0.1%	131,881	12/31/2021
2021 Q3	11/3/2021	14,888	0.1%	135,905	9/30/2021
2021 Q2	8/12/2021	14,206	0.1%	151,716	6/30/2021
2021 Q1	5/13/2021	12,571	0.1%	136,551	3/31/2021
2020 Q4	2/12/2021	12,385	0.1%	169,314	12/31/2020
2020 Q3	11/13/2020	12,443	0.2%	160,178	9/30/2020
2020 Q2	8/14/2020	6,822	0.1%	122,746	6/30/2020
2020 Q1	5/14/2020	4,256	0.1%	143,650	3/31/2020
2019 Q4	2/11/2020	4,718	0.1%	130,354	12/31/2019